{
    "id": 13917,
    "cites": 29,
    "cited_by": 8,
    "reference": [
        "Acemoglu, Daron, David Cutler, Amy Finkelstein, and Joshua Linn (2006). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Did Medicare Induce Pharmaceutical Innovation?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d AEA Papers and Proceedings.",
        "Arrow, Kenneth (1963). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Uncertainty and the Welfare Economics of Medical Care.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review 53: 941-973.",
        "Caves, Richard, Michael Whinston, and Michael Hurwitz (1991). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Brookings Papers on Economic Activity.",
        "Centers for Medicare and Medicaid Services (2007a). Medicare and Medicaid Statistical Supplement.",
        "Centers for Medicare and Medicaid Services (2007b). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Strong Competition and Beneficiary Choices Contribute to Medicare Drug Coverage with Lower Costs than Predicted.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d CMS Fact Sheet released on August 13, 2007.",
        "Cogan, John, R. Glenn Hubbard, and Daniel Kessler (2005). Healthy, Wealthy, and Wise: Five Steps to a Better Health Care System. American Enterprise Institute Press.",
        "Cutler, David (2995) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Incidence of Adverse Medical Outcomes under Prospective Payment.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Econometrica 63: 29-50.",
        "Dafny, Leemore (2005). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How Do Hospitals Respond to Price Changes?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review.: 95 (5) 1525-47.",
        "Davidson, Carl and Deneckere, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Incentives for form coalitions with Bertrand competition\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d (Winter 1985) RAND Journal of Economics: 16:4:473-486.",
        "Dimasi, Joseph, Ronald Hansen, and Henry Grabowski (2003). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Price of Innovation: New Estimates of Drug Development Costs.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Health Economics 22(2) 151-185.",
        "Duggan, Mark (2005). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do New Prescription Drugs Pay for Themselves? The Case of SecondGeneration Antipsychotics.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Health Economics, 1-31.",
        "Duggan, Mark and Scott Morton, Fiona (2006) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The distortionary effects of government procurement: evidence from Medicaid prescription drug purchasing\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics:121:1:130.",
        "Duggan, Mark, Patrick Healy, and Fiona Scott Morton (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How Does Medicare Part D Work?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d forthcoming, Journal of Economic Perspectives Evans, Robert (1974). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Supplier-Induced Demand: Some Empirical Evidence and Implications.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d In: M. Perlman, ed., The Economics of Health and Medical Care (Macmillan, London) 162-173.",
        "Finkelstein, Amy (2007) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics:122:1:1-37.",
        "Finkelstein and McKnight (2007). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093What Did Medicare Do? The Initial Impact of Medicare on Mortality and Out-of-Pocket Spending.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Forthcoming in the Journal of Public Economics.",
        "Frank, Richard and David Salkever (1997). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Generic Entry and the Pricing of Pharmaceuticals.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economics and Management Strategy 6: 75-90.",
        "Frank, Richard and Joseph Newhouse (2008). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Should Drug Prices Be Negotiated Under Part D of Medicare? And If So, How?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs 27 (1): 33-43.",
        "Gibson, Teresa, Ronald Ozminkowski, and Ron Goetzel (2005). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effects of Prescription Drug Cost Sharing: A Review of the Evidence.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Managed Care 11: 730-740.",
        "Huskamp, Haiden et al. (2003). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effect of Incentive-Based Formularies on Prescription Drug Utilization and Spending.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New England Journal of Medicine 349: 2224-2232.",
        "Khwaja, Ahmed. (2008). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Life Cycle Analysis of the Effects of Medicare on Individual Health Incentives and Health Outcomes.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Duke University mimeo.",
        "Lichtenberg, Frank and Shawn Sun (2007) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Impact of Part D on Prescription Drug Use By The Elderly\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs:26:6:1-10 Lucarelli, Claudio and Kosali Simon (2006) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093What Drove First Year Premiums in Stand-Alone Medicare Drug Plans?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d working paper, Cornell University.",
        "Manning et al (1987). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review 77: 251-277.",
        "Merlis, Mark (2007). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medicare Payments and Beneficiary Costs for Prescription Drug Coverage.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Prepared for the Henry J. Kaiser Family Foundation.",
        "Pavcnik, Nina (2002) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d RAND Journal of Economics 33 (3): 469-487.",
        "Scott Morton, Fiona (1997) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Strategic Response by Pharmaceutical Firms to the Medicaid MostFavored -Customer Rules\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The RAND Journal of Economics:28:2:269-290.",
        "Shubik, Martin (1980) Market Structure and Behavior. Harvard University Press, Cambridge, Massachusetts.",
        "Social Security Administration (2007). Annual Statistical Supplement to the Social Security Bulletin. SSA Publication 13-11700.",
        "Yang, Zhou, Donna Gilleskie, and Edward Norton (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Health Insurance, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d forthcoming in the Journal of Human Resources.",
        "Yin, Wesley, Anirban Basu, James Zhang, Atonu Rabbani, David Meltzer, and Caleb Alexander (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Annals of Internal Medicine 148 (3): 169-177."
    ]
}